<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.2?><?ConverterInfo.XSLTName jats2jats3.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Chem Sci</journal-id><journal-id journal-id-type="iso-abbrev">Chem Sci</journal-id><journal-id journal-id-type="publisher-id">SC</journal-id><journal-id journal-id-type="coden">CSHCBM</journal-id><journal-title-group><journal-title>Chemical Science</journal-title></journal-title-group><issn pub-type="ppub">2041-6520</issn><issn pub-type="epub">2041-6539</issn><publisher><publisher-name>The Royal Society of Chemistry</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">8163387</article-id><article-id pub-id-type="publisher-id">d0sc02676j</article-id><article-id pub-id-type="doi">10.1039/d0sc02676j</article-id><article-categories><subj-group subj-group-type="heading"><subject>Chemistry</subject></subj-group></article-categories><title-group><article-title>Mechanistic insight into hydroxamate transfer reaction mimicking the inhibition of zinc-containing enzymes<xref ref-type="fn" rid="fn1">&#x02020;</xref></article-title><fn-group><fn id="fn1"><label>&#x02020;</label><p>Electronic supplementary information (ESI) available. CCDC <uri>1847955</uri> and <uri>1864483</uri>. For ESI and crystallographic data in CIF or other electronic format see DOI: <uri>10.1039/d0sc02676j</uri></p></fn></fn-group></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kwon</surname><given-names>Nam</given-names></name><xref ref-type="aff" rid="affa"/><xref ref-type="author-notes" rid="fn2">&#x02021;</xref></contrib><contrib contrib-type="author"><name><surname>Suh</surname><given-names>Jong-Min</given-names></name><xref ref-type="aff" rid="affb"/><xref ref-type="author-notes" rid="fn2">&#x02021;</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-3377-4996</contrib-id><name><surname>Lim</surname><given-names>Mi Hee</given-names></name><xref ref-type="aff" rid="affb"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-8239-3471</contrib-id><name><surname>Hirao</surname><given-names>Hajime</given-names></name><xref ref-type="aff" rid="affc"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-2712-4295</contrib-id><name><surname>Cho</surname><given-names>Jaeheung</given-names></name><xref ref-type="aff" rid="affa"/></contrib><aff id="affa">
<institution>Department of Emerging Materials Science, DGIST</institution>
<city>Daegu 42988</city>
<country>Korea</country>
<email>jaeheung@dgist.ac.kr</email>
</aff><aff id="affb">
<institution>Department of Chemistry, KAIST</institution>
<city>Daejeon 34141</city>
<country>Korea</country>
</aff><aff id="affc">
<institution>Department of Chemistry, City University of Hong Kong</institution>
<addr-line>Tat Chee Avenue</addr-line>
<city>Kowloon</city>
<country>Hong Kong</country>
</aff></contrib-group><author-notes><fn id="fn2"><label>&#x02021;</label><p>These authors contributed equally to this work.</p></fn></author-notes><pub-date publication-format="electronic" date-type="pub" iso-8601-date="2020-08-13"><day>13</day><month>8</month><year>2020</year></pub-date><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2020-09-07"><day>7</day><month>9</month><year>2020</year></pub-date><pub-date pub-type="pmc-release"><day>13</day><month>8</month><year>2020</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>11</volume><issue>33</issue><fpage>9017</fpage><lpage>9021</lpage><history><date date-type="received" iso-8601-date="2020-05-11"><day>11</day><month>5</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-08-10"><day>10</day><month>8</month><year>2020</year></date></history><permissions><copyright-statement>This journal is &#x000a9; The Royal Society of Chemistry</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>The Royal Society of Chemistry</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense" start_date="2020-08-13">https://creativecommons.org/licenses/by-nc/3.0/</ali:license_ref></license><?release-delay 0|0?></permissions><abstract><p>A hydroxamate transfer reaction between metal complexes has been investigated by a combination of experimental and theoretical studies. A hydroxamate-bound cobalt(<sc>ii</sc>) complex bearing a tetradentate macrocyclic ligand, [Co<sup>II</sup>(TBDAP)(CH<sub>3</sub>C(&#x02013;NHO)O)]<sup>+</sup> (<bold>1</bold>), is prepared by the reduction of a hydroximatocobalt(<sc>iii</sc>) complex with a biological reductant. Alternatively, <bold>1</bold> is accessible <italic>via</italic> a synthetic route for the reaction between the cobalt(<sc>ii</sc>) complex and acetohydroxamic acid in the presence of a base. <bold>1</bold> was isolated and characterized by various physicochemical methods, including UV-vis, IR, ESI-MS, and X-ray crystallography. The hydroxamate transfer reactivity of <bold>1</bold> was examined with a zinc complex, which was followed by UV-vis and ESI-MS. Kinetic and activation parameter data suggest that the hydroxamate transfer reaction occurs <italic>via</italic> a bimolecular mechanism, which is also supported by DFT calculations. Moreover, <bold>1</bold> is able to inhibit the activity against a zinc enzyme, <italic>i.e.</italic>, matrix metalloproteinase-9. Our overall investigations of the hydroxamate transfer using the synthetic model system provide considerable insight into the final step involved in the inhibition of zinc-containing enzymes.</p></abstract><abstract abstract-type="toc"><p>A hydroxamate transfer reaction between metal complexes has been investigated by a combination of experimental and theoretical studies.<graphic xlink:href="d0sc02676j-ga.jpg" id="ga" position="float" orientation="portrait"/></p></abstract><funding-group><award-group><funding-source><institution-wrap><institution>City University of Hong Kong</institution><institution-id institution-id-type="doi">10.13039/100007567</institution-id></institution-wrap></funding-source><award-id>9610369</award-id></award-group><award-group><funding-source><institution-wrap><institution>National Research Foundation of Korea</institution><institution-id institution-id-type="doi">10.13039/501100003725</institution-id></institution-wrap></funding-source><award-id>2019R1A2C2086249</award-id><award-id>2018R1A5A1025511</award-id><award-id>2017R1A2B3002585</award-id></award-group><award-group><funding-source><institution-wrap><institution>Ministry of Science, ICT and Future Planning</institution><institution-id institution-id-type="doi">10.13039/501100003621</institution-id></institution-wrap></funding-source><award-id>CGRC 2016M3D3A01913243</award-id></award-group></funding-group><counts><page-count count="5"/></counts><custom-meta-group><custom-meta><meta-name>pubstatus</meta-name><meta-value>Paginated Article</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec><title>Introduction</title><p>Hydroxamic acids are important pharmacophores in diverse biological functions such as antimicrobial activity and metal detoxification.<sup><xref rid="cit1" ref-type="bibr">1&#x02013;5</xref></sup> The derivatives of hydroxamic acids are well known as zinc-binding groups; thus, they can inhibit the activity of zinc-containing enzymes, including carbonic anhydrase, histone deacetylase and carboxypeptidase.<sup><xref rid="cit6" ref-type="bibr">6&#x02013;11</xref></sup> So far, hydroxamic acids have also been considered as highly promising anticancer reagents: they can serve as inhibitors of matrix metalloproteinases (MMPs) that are overexpressed in cancer cells and cause tumor invasion and metastasis.<sup><xref rid="cit12" ref-type="bibr">12&#x02013;17</xref></sup> The use of hydroxamate functional groups as traditional anticancer reagents, however, is rather restricted within tumor cells because the environment disrupts drug supply.<sup><xref rid="cit18" ref-type="bibr">18&#x02013;21</xref></sup></p><p>Recently, numerous hydroxamate-bound metal complexes have been explored as prodrugs targeting cancer cells. For example, cobalt(<sc>iii</sc>) complexes of hydroxamic acids are reported to be potential prodrugs for hypoxia-selective anticancer agents.<sup><xref rid="cit22" ref-type="bibr">22&#x02013;25</xref></sup> As shown in <xref ref-type="scheme" rid="sch1">Scheme 1</xref>, Hambley and co-workers have provided experimental support for two possible pathways of releasing the hydroxamate group (<italic>i.e.</italic>, bio-reduction and endogenous ligand exchange pathways).<sup><xref rid="cit22" ref-type="bibr">22,26</xref></sup> Recent studies on the characterization and reactivity of cobalt(<sc>iii</sc>)-hydroximato and -hydroxamato complexes bearing TPA ligands revealed their redox behaviors and ligand exchange reactions.<sup><xref rid="cit27" ref-type="bibr">27,28</xref></sup> Little is known about the molecular-level mechanism of the hydroxamate transfer, which is the final step of inhibiting the activity of zinc-containing enzymes by hydroxamate, however.</p><fig id="sch1" fig-type="scheme" orientation="portrait" position="float"><label>Scheme 1</label><caption><title>Proposed pathways for the release of hydroxamate (HA).</title></caption><graphic xlink:href="d0sc02676j-s1"/></fig><p>Herein, we report a novel approach to investigate the hydroxamate transfer activity of a hydroxamatocobalt(<sc>ii</sc>) complex, [Co<sup>II</sup>(TBDAP)(CH<sub>3</sub>C(&#x02013;NHO)O)]<sup>+</sup> (<bold>1</bold>; TBDAP = <italic>N</italic>,<italic>N</italic>-di-<italic>tert</italic>-butyl-2,11-diaza[3.3](2,6)-pyridinophane), which is derived from the reduction of [Co<sup>III</sup>(TBDAP)(CH<sub>3</sub>C(<private-char name="DOUBLE BOND, LENGTH AS M-DASH" description="double bond, length as m-dash"><!-- PBM data was replaced with SVG by xgml2pxml:
<glyph-data id="z.dbd" format="PBM" resolution="300" x-size="8" y-size="10" xml:space="preserve">
00000000
00000000
00000000
00000000
11111111
00000000
11111111
00000000
00000000
00000000
</glyph-data>
-->
<glyph-data id="z.dbd" format="SVG" resolution="300" x-size="8" y-size="10" xml:space="preserve">
<![CDATA[
<svg xmlns="http://www.w3.org/2000/svg" version="1.0" width="13.200000pt" height="16.000000pt" viewBox="0 0 13.200000 16.000000" preserveAspectRatio="xMidYMid meet"><metadata>
Created by potrace 1.16, written by Peter Selinger 2001-2019
</metadata><g transform="translate(1.000000,15.000000) scale(0.017500,-0.017500)" fill="currentColor" stroke="none"><path d="M0 440 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z M0 280 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z"/></g></svg>
]]>
</glyph-data></private-char>NO)O)]<sup>+</sup> (<bold>2</bold>).<sup><xref rid="cit29" ref-type="bibr">29</xref></sup><bold>1</bold> was characterized by X-ray crystallography and multiple spectroscopic methods. To the best of our knowledge, <bold>1</bold> represents a rare example of a structurally characterized cobalt(<sc>ii</sc>) complex bearing an acetohydroxamate ligand that has been prepared by the reaction of a hydroximatocobalt(<sc>iii</sc>) complex with a biological reductant. In this work, we have examined the mechanism of the hydroxamate transfer from <bold>1</bold> towards a zinc complex which is a model of zinc-containing active sites in enzymes.<sup><xref rid="cit30" ref-type="bibr">30</xref></sup> Kinetic studies and density functional theory (DFT) calculations support the notion that the hydroxamate transfer occurs through a bimolecular mechanism. Moreover, <bold>1</bold> performs the better inhibitory activity against matrix metalloproteinase-9 (MMP-9), compared to <bold>2</bold>.</p></sec><sec><title>Results and discussion</title><p>The hydroxamatocobalt(<sc>ii</sc>) complex, <bold>1</bold>, was synthesized by reacting 1 equiv. of acetohydroxamic acid in CH<sub>3</sub>CN with a starting Co<sup>II</sup> complex, [Co<sup>II</sup>(TBDAP)(NO<sub>3</sub>)(H<sub>2</sub>O)]<sup>+</sup>, in the presence of 2 equiv. of triethylamine (TEA) under ambient conditions, where the solution color changed from pink to orange. The UV-vis spectrum of <bold>1</bold> in CH<sub>3</sub>CN at 25 &#x000b0;C revealed two characteristic absorption bands at <italic>&#x003bb;</italic><sub>max</sub> = 361 (<italic>&#x003b5;</italic> = 1900 M<sup>&#x02212;1</sup> cm<sup>&#x02212;1</sup>) and 468 nm (<italic>&#x003b5;</italic> = 100 M<sup>&#x02212;1</sup> cm<sup>&#x02212;1</sup>). The electrospray ionization mass spectrometry (ESI-MS) spectrum of <bold>1</bold> showed a single signal at mass-to-charge (<italic>m</italic>/<italic>z</italic>) ratio of 485.3 (calcd <italic>m</italic>/<italic>z</italic> 485.2); the mass and isotope distribution pattern correspond to [Co(TBDAP)(CH<sub>3</sub>C(&#x02013;NHO)O)]<sup>+</sup> (Fig. S1<xref ref-type="fn" rid="fn1">&#x02020;</xref>). The FT-IR spectrum of <bold>1</bold> revealed the existence of N&#x02013;H vibrational frequency at 3206 cm<sup>&#x02212;1</sup>, which also corroborates the hypothesis that acetohydroxamic acid is bound in the form of singly deprotonated monoanionic hydroxamate rather than doubly deprotonated dianionic hydroximate (Fig. S2<xref ref-type="fn" rid="fn1">&#x02020;</xref>).<sup><xref rid="cit31" ref-type="bibr">31</xref></sup> The effective magnetic moment of <bold>1</bold> (<italic>&#x003bc;</italic><sub>eff</sub> = 4.41 B.M.) was determined using the <sup>1</sup>H NMR spectroscopy method of Evans in CD<sub>3</sub>CN at 25 &#x000b0;C,<sup><xref rid="cit32" ref-type="bibr">32</xref></sup> suggesting the high spin state (<italic>S</italic> = 3/2) of the Co<sup>II</sup> ion (see ESI<xref ref-type="fn" rid="fn1">&#x02020;</xref>). <bold>1</bold> has a slightly higher effective magnetic moment due to spin&#x02013;orbit coupling.<sup><xref rid="cit33" ref-type="bibr">33</xref></sup> Thus, <bold>1</bold> is characterized as the cobalt(<sc>ii</sc>) complex with the singly deprotonated hydroxamate ligand.</p><p>The X-ray crystal structure of <bold>1</bold> reveals a mononuclear acetohydroxamate cobalt complex in a distorted octahedral geometry, in which the hydroxamate group coordinated in a bidentate mode (<xref ref-type="fig" rid="fig1">Fig. 1</xref>). The average Co&#x02013;O bond length (2.034 &#x000c5;) in <bold>1</bold> is similar to that of the hydroxamatocobalt(<sc>ii</sc>) complex with 6-(Me<sub>2</sub>Ph)<sub>2</sub>TPA ligand (2.038 &#x000c5;)<sup><xref rid="cit34" ref-type="bibr">34</xref></sup> but is longer than that in <bold>2</bold> (1.856 &#x000c5;) and other hydroximatocobalt(<sc>iii</sc>) complexes.<sup><xref rid="cit24" ref-type="bibr">24,25,27&#x02013;29,35</xref></sup><bold>1</bold> is the rare example of a structurally characterized hydroxamatocobalt(<sc>ii</sc>) complex, which would be a reactive species towards inhibition of metalloenzymes.</p><fig id="fig1" orientation="portrait" position="float"><label>Fig. 1</label><caption><title>ORTEP diagram of the hydroxamatocobalt(<sc>ii</sc>) complex, [Co<sup>II</sup>(TBDAP)(CH<sub>3</sub>C(&#x02013;NHO)O)]<sup>+</sup> (<bold>1</bold>), with thermal ellipsoids drawn at the 30% probability level. All hydrogen atoms except H1 are omitted for clarity. H1 was found in the Fourier difference map.</title></caption><graphic xlink:href="d0sc02676j-f1"/></fig><p>It has been proposed that the hydroxamatocobalt(<sc>ii</sc>) species is a key intermediate in the inhibition against MMP.<sup><xref rid="cit22" ref-type="bibr">22,23</xref></sup> We investigated the intermolecular transfer of the hydroxamate group from <bold>1</bold> to a zinc complex, [Zn<sup>II</sup>(Me<sub>3</sub>-TACN)(NO<sub>3</sub>)]<sup>+</sup> (<bold>3</bold>), which is a model of the active site of MMP (Scheme S1<xref ref-type="fn" rid="fn1">&#x02020;</xref>).<sup><xref rid="cit30" ref-type="bibr">30</xref></sup> Upon addition of <bold>3</bold> to <bold>1</bold>, the characteristic absorption band of <bold>1</bold> disappeared (<xref ref-type="fig" rid="fig2">Fig. 2a</xref>). The hydroxamate transfer from <bold>1</bold> to <bold>3</bold> was confirmed by ESI-MS analysis in the course of the reaction, where the mass peak at <italic>m</italic>/<italic>z</italic> 485.3 corresponding to <bold>1</bold> vanished with a concomitant appearance of the mass peak at <italic>m</italic>/<italic>z</italic> 309.2 corresponding to [Zn<sup>II</sup>(Me<sub>3</sub>-TACN)(CH<sub>3</sub>C(&#x02013;NHO)O)]<sup>+</sup> (<bold>4</bold>) (<xref ref-type="fig" rid="fig2">Fig. 2b</xref>). Many attempts to isolate the product as single crystals have been unsuccessful. The structural information was obtained from an alternative synthetic route: the complex <bold>4</bold> was crystallized from the solution of the reaction mixture of <bold>3</bold> and excess acetohydroxamic acid in the presence of TEA (see ESI and Fig. S3<xref ref-type="fn" rid="fn1">&#x02020;</xref>). Although the equilibrium constant (<italic>K</italic><sub>eq</sub> = 5.9 &#x000d7; 10<sup>&#x02212;2</sup>) of the transfer reaction determined by optical titrations is small (Fig. S4<xref ref-type="fn" rid="fn1">&#x02020;</xref>), the reaction readily occurs upon the addition of an excess amount of <bold>3</bold>.</p><fig id="fig2" orientation="portrait" position="float"><label>Fig. 2</label><caption><title>Reaction of <bold>1</bold> with <bold>3</bold>. (a) UV-vis spectral change during the reaction of <bold>1</bold> (0.25 mM) with <bold>3</bold> (10 mM) in CH<sub>3</sub>CN/H<sub>2</sub>O (99&#x02009;:&#x02009;1) at &#x02212;10 &#x000b0;C. Inset shows the decrease of concentration of <bold>1</bold> with increasing concentration of <bold>3</bold>. (b) ESI-MS spectra obtained for the reaction of <bold>1</bold> (0.25 mM) with <bold>3</bold> (25 mM) before (lower) and after (upper) the reaction. The peaks at <italic>m</italic>/<italic>z</italic> 309.2 and 485.3 are assigned to [Zn<sup>II</sup>(Me<sub>3</sub>-TACN)(CH<sub>3</sub>C(&#x02013;NHO)O)]<sup>+</sup> (calcd <italic>m</italic>/<italic>z</italic> 309.1) and [Co<sup>II</sup>(TBDAP)(CH<sub>3</sub>C(&#x02013;NHO)O)]<sup>+</sup> (calcd <italic>m</italic>/<italic>z</italic> 485.2), respectively.</title></caption><graphic xlink:href="d0sc02676j-f2"/></fig><p>Kinetic studies of the hydroxamate group transfer reaction from <bold>1</bold> to <bold>3</bold> were carried out in a mixture of CH<sub>3</sub>CN and H<sub>2</sub>O (99&#x02009;:&#x02009;1). Upon addition of <bold>3</bold> (2.5 mM) to the solution of <bold>1</bold> (0.25 mM) at &#x02212;10 &#x000b0;C, the characteristic absorption bands of <bold>1</bold> decayed (<xref ref-type="fig" rid="fig2">Fig. 2</xref>). The rate constant increased with the concentration of <bold>3</bold>, providing a second-order rate constant (<italic>k</italic><sub>2</sub>) of 4.0(2) M<sup>&#x02212;1</sup> s<sup>&#x02212;1</sup> (<xref ref-type="fig" rid="fig3">Fig. 3a</xref>). The temperature dependence of the <italic>k</italic><sub>2</sub> value was investigated in the range of 253&#x02013;283 K, from which a linear Eyring plot was obtained with activation parameters of &#x00394;<italic>H</italic><sup>&#x02021;</sup> = 59(3) kJ mol<sup>&#x02212;1</sup> and &#x00394;<italic>S</italic><sup>&#x02021;</sup> = &#x02212;5(1) J mol<sup>&#x02212;1</sup> K<sup>&#x02212;1</sup> (<xref ref-type="fig" rid="fig3">Fig. 3b</xref>). The observed data suggest that the hydroxamate transfer reaction occurs through a bimolecular mechanism, in which the formation of an undetected [(TBDAP)Co&#x02013;(CH<sub>3</sub>C(&#x02013;NHO)O)&#x02013;Zn(Me<sub>3</sub>-TACN)]<sup>3+</sup> species is the rate-determining step.</p><fig id="fig3" orientation="portrait" position="float"><label>Fig. 3</label><caption><title>Rate and activation parameters for the reaction of <bold>1</bold> with <bold>3</bold> in CH<sub>3</sub>CN/H<sub>2</sub>O (99&#x02009;:&#x02009;1). (a) Plot of <italic>k</italic><sub>obs</sub> against the concentration of <bold>3</bold> at &#x02212;10 &#x000b0;C to determine a second-order rate constant (<italic>k</italic><sub>2</sub>). (b) Eyring plot of ln(<italic>k</italic><sub>2</sub>/<italic>T</italic>) against 1/<italic>T</italic> to obtain the activation parameters.</title></caption><graphic xlink:href="d0sc02676j-f3"/></fig><p>DFT calculations were performed for the hydroxamate transfer reaction (see ESI<xref ref-type="fn" rid="fn1">&#x02020;</xref>). According to the DFT results (<xref ref-type="fig" rid="fig4">Fig. 4</xref>), the oxygen atom in the NHO<sup>&#x02212;</sup> moiety of hydroxamate in the Co(<sc>ii</sc>) complex is first coordinated by the Zn(<sc>ii</sc>) complex at <bold>Int1</bold>. Subsequently, the carbonyl oxygen of hydroxamate is transferred from the Co(<sc>ii</sc>) center to the Zn(<sc>ii</sc>) center <italic>via</italic> a transition state (<bold>TS1</bold>) to form a product complex (<bold>Int3</bold>). The free energy profile also suggests that the reaction is not a very favorable process thermodynamically, which is reasonably consistent with the small equilibrium constant (<italic>vide supra</italic>).</p><fig id="fig4" orientation="portrait" position="float"><label>Fig. 4</label><caption><title>(a) DFT-calculated free energy profile (in kcal mol<sup>&#x02212;1</sup>) for the hydroxamate transfer reaction. L and L&#x02032; denote the ligands for the Co and Zn complexes, respectively. (b) Optimized geometry of <bold>TS1</bold>, with key distances shown in &#x000c5;.</title></caption><graphic xlink:href="d0sc02676j-f4"/></fig><p>On the other hand, upon addition of <bold>3</bold> to a solution of <bold>2</bold> (0.5 mM), <bold>2</bold> remained intact without showing any absorption spectral change (Fig. S5a<xref ref-type="fn" rid="fn1">&#x02020;</xref>), indicating that <bold>2</bold> is not able to conduct the hydroxamate group transfer reaction. The ESI-MS spectrum of the reaction solutions confirmed that no transferred product was formed (Fig. S5b<xref ref-type="fn" rid="fn1">&#x02020;</xref>). Notably, the transfer reaction occurs by adding a biological reductant such as ascorbic acid, which is a 2H<sup>+</sup>/2e<sup>&#x02212;</sup> donor. Addition of 0.5 equiv. of ascorbic acid to a reaction mixture of <bold>2</bold> and <bold>3</bold> resulted in the conversion of <bold>2</bold> to <bold>1</bold>, and then the hydroxamate in <bold>1</bold> was transferred to <bold>3</bold> (Fig. S6a<xref ref-type="fn" rid="fn1">&#x02020;</xref>). After the reaction had been completed, <bold>4</bold> was produced, which was confirmed by ESI-MS (Fig. S6b<xref ref-type="fn" rid="fn1">&#x02020;</xref>).</p><p>The cyclic voltammograms of <bold>1</bold> and <bold>2</bold> in CH<sub>3</sub>CN exhibit a reversible couple between the Co(<sc>ii</sc>) and Co(<sc>iii</sc>) complexes (Fig. S7<xref ref-type="fn" rid="fn1">&#x02020;</xref>). From the <italic>E</italic><sub>1/2</sub> values, the one-electron redox potentials of <bold>1</bold> and <bold>2</bold> were determined to be 0.28 and &#x02212;0.47 V (<italic>versus</italic> SCE), respectively. The redox potential of <bold>2</bold> is more negative than that of ascorbic acid.<sup><xref rid="cit36" ref-type="bibr">36</xref></sup> In earlier studies, however, the protonation of hydroximatocobalt(<sc>iii</sc>) complexes resulted in more positive potential affording facile reduction.<sup><xref rid="cit27" ref-type="bibr">27</xref></sup> The proton-assisted reduction process was confirmed by the cyclic voltammetry (CV) experiments, where the redox signal of <bold>2</bold> disappeared with the concomitant generation of the redox signal of <bold>1</bold> upon addition of proton (Fig. S8<xref ref-type="fn" rid="fn1">&#x02020;</xref>). Alternatively, the hydroxamatocobalt(<sc>iii</sc>) complex, [Co<sup>III</sup>(TBDAP)(CH<sub>3</sub>C(&#x02013;NHO)O)]<sup>2+</sup> (<bold>5</bold>), which is not only a protonated form of <bold>2</bold> but also an one electron oxidized species of <bold>1</bold>, was prepared by the reaction of <bold>2</bold> with 1 equiv. of HClO<sub>4</sub> (Fig. S11<xref ref-type="fn" rid="fn1">&#x02020;</xref>). The formation of <bold>5</bold> was confirmed by UV-vis and ESI-MS (Fig. S12<xref ref-type="fn" rid="fn1">&#x02020;</xref>). <bold>2</bold> and <bold>5</bold> are interconvertible through the acid&#x02013;base chemistry.</p><p>In order to verify the influence of <bold>1</bold>, relative to acetohydroxamic acid or <bold>2</bold>, on a zinc-containing enzyme, their inhibitory activity against MMP-9 was evaluated. After incubation of activated MMP-9 with a peptide as a substrate in the presence of <bold>1</bold>, <bold>2</bold>, or acetohydroxamic acid, the amount of the substrate that was not cleaved by the enzyme was analyzed. Inhibition against MMP-9 by <bold>1</bold> and <bold>2</bold>, relative to that by acetohydroxamic acid, was 77(2)% and 24(3)%, respectively. The more noticeable inhibitory activity of <bold>1</bold> than <bold>2</bold> against MMP-9 was expected from our reactivity and mechanistic studies (<italic>vide supra</italic>).</p><p>To visualize possible interactions between <bold>1</bold> and MMP-9 at the molecular level, docking studies were carried out employing the catalytic domain of MMP-9 (PDB <uri>4H3X</uri>).<sup><xref rid="cit37" ref-type="bibr">37</xref></sup> As illustrated in <xref ref-type="fig" rid="fig5">Fig. 5</xref>, <bold>1</bold> could access to the catalytic cleft of MMP-9 where three histidine residues (<italic>i.e.</italic>, H226, H230, and H236) are coordinated to the active Zn(<sc>ii</sc>) center. According to the docked structures, <bold>1</bold> may have multiple contacts with the catalytic domain of MMP-9: (i) hydrogen bonding {[C&#x02013;H from <bold>1</bold> and oxygen (O) donor atoms from A189, A191, E227, and D235; a nitrogen (N) donor atom from H236] and [C&#x02013;H from H236 and an O donor atom from <bold>1</bold>]} and (ii) C&#x02013;H&#x022ef;&#x003c0; interaction (C&#x02013;H from the side chain of L187 and H236 and pyridine groups from <bold>1</bold>). In addition, the representative conformations exhibited the possibility of the hydroxamate moiety onto <bold>1</bold> to be located close to the Zn(<sc>ii</sc>) center in the catalytic domain of MMP-9. Collectively, <bold>1</bold> may interact with the catalytic site of MMP-9.</p><fig id="fig5" orientation="portrait" position="float"><label>Fig. 5</label><caption><title>Two possible representative conformations of <bold>1</bold> docked with the catalytic domain of MMP-9 (PDB <uri>4H3X</uri>) by AutoDock Vina [surface (left) and cartoon (right) versions]. These conformations exhibited the calculated binding energies in a range from &#x02212;5.5 to &#x02212;3.5 kcal mol<sup>&#x02212;1</sup>. Hydrogen bonding and C&#x02013;H&#x022ef;&#x003c0; interactions within 3.0 &#x000c5; are indicated with dashed lines. The Zn(<sc>ii</sc>) center in the catalytic domain of MMP-9 is highlighted as an orange sphere.</title></caption><graphic xlink:href="d0sc02676j-f5"/></fig><p>To explore how the substituent onto the ligand affects the hydroxamate transfer reactivity towards <bold>3</bold> and the inhibitory activity of Co(<sc>ii</sc>) complexes against MMP-9, a benzohydroxamatocobalt(<sc>ii</sc>) complex, [Co<sup>II</sup>(TBDAP)(C<sub>6</sub>H<sub>5</sub>C(&#x02013;NHO)O)]<sup>+</sup> (<bold>6</bold>), was prepared (see ESI<xref ref-type="fn" rid="fn1">&#x02020;</xref>). Kinetic studies for the reaction of <bold>6</bold> with <bold>3</bold> were carried out, affording <italic>k</italic><sub>2</sub> of 4.9(5) &#x000d7; 10<sup>&#x02212;1</sup> M<sup>&#x02212;1</sup> s<sup>&#x02212;1</sup> at &#x02212;10 &#x000b0;C (Fig. S16 and S17<xref ref-type="fn" rid="fn1">&#x02020;</xref>). The equilibrium constant for the transfer reaction from <bold>6</bold> was also determined as 4.4 &#x000d7; 10<sup>&#x02212;2</sup> (Fig. S18<xref ref-type="fn" rid="fn1">&#x02020;</xref>). These results are similar to those of the hydroxamate transfer reaction of <bold>1</bold>. Under our experimental conditions, the inhibitory activity of <bold>6</bold> towards MMP-9 was same as that of <bold>1</bold> (data not shown). Thus, replacing a structural moiety of the ligand from acetohydroxamate to benzohydroxamate may not significantly change the hydroxamate transfer reactivity towards <bold>3</bold> and the inhibitory activity of its corresponding Co(<sc>ii</sc>) complex against MMP-9.</p><p>Based on the experimental and computational studies, it is suggested that the hydroxamate transfer can be accelerated in the presence of a weak acid, which reduces the coordination ability of the hydroxamate group in the hydroxamatocobalt(<sc>ii</sc>) complex. Thus, we further investigated the equilibrium between <bold>1</bold> and <bold>4</bold> under acidic conditions. By adding acetic acid to the solution of <bold>1</bold> and <bold>3</bold>, the absorption band of <bold>1</bold> exponentially decreased with increasing concentration of the acetic acid (Fig. S19<xref ref-type="fn" rid="fn1">&#x02020;</xref>). This result indicates that, in the presence of acetic acid, the equilibrium is shifted in favor of <bold>4</bold>, which was also confirmed by ESI-MS (Fig. S20<xref ref-type="fn" rid="fn1">&#x02020;</xref>). Taken together, the hydroxamate transfer reaction effectively occurs in relatively acidic conditions.</p></sec><sec><title>Conclusions</title><p>We have succeeded in the isolation and structural characterization of a hydroxamatocobalt(<sc>ii</sc>) complex bearing macrocyclic tetradentate N4 ligand, [Co<sup>II</sup>(TBDAP)(CH<sub>3</sub>C(&#x02013;NHO)O)]<sup>+</sup> (<bold>1</bold>), in which the acetohydroxamate ligand is bound in a bidentate mode. The intermediate is further characterized by various physicochemical methods such as FT-IR, UV-vis, and ESI-MS. <bold>1</bold> exhibited hydroxamate group transfer reactivity towards a zinc(<sc>ii</sc>) complex. The observation of the hydroxamate transfer between metal complexes is unprecedented. In addition, the proton-assisted reduction mechanism was examined by the CV measurements. Kinetic studies suggest that the transfer reaction proceeds by a bimolecular mechanism, which is supported by DFT calculations. Moreover, the inhibitory activity of <bold>1</bold> towards a zinc-containing enzyme, MMP-9, was confirmed. The interaction and accessibility of <bold>1</bold> to MMP-9 as well as the substitution effect onto the hydroxamate ligand were also examined.</p></sec><sec sec-type="COI-statement"><title>Conflicts of interest</title><p>There are no conflicts to declare.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SC-011-D0SC02676J-s001"><label>SC-011-D0SC02676J-s001</label><media xlink:href="SC-011-D0SC02676J-s001.pdf" orientation="portrait" id="d24e1080" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SC-011-D0SC02676J-s002"><label>SC-011-D0SC02676J-s002</label><media xlink:href="SC-011-D0SC02676J-s002.cif" orientation="portrait" id="d24e1083" position="anchor"/></supplementary-material></sec></body><back><ack><p>J. C. at DGIST acknowledges the financial support from the NRF (2019R1A2C2086249 and 2018R1A5A1025511) and the Ministry of Science, ICT and Future Planning (MSIP) (CGRC 2016M3D3A01913243) of Korea. M. H. L was supported by the NRF funded by the MSIP (2017R1A2B3002585). H. H. acknowledges the support of City University of Hong Kong (9610369).</p></ack><ref-list><title>Notes and references</title><ref id="cit1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Apfel</surname><given-names>C.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Banner</surname><given-names>D. W.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Bur</surname><given-names>D.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Dietz</surname><given-names>M.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Hirata</surname><given-names>T.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Hubschwerlen</surname><given-names>C.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Locher</surname><given-names>H.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Page</surname><given-names>M. G. P.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Pirson</surname><given-names>W.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Rosse</surname><given-names>G.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Specklin</surname><given-names>J.-L.</given-names></name></person-group><source>J. Med. Chem.</source><year>2000</year><volume>43</volume><fpage>2324</fpage><lpage>2331</lpage><pub-id pub-id-type="doi">10.1021/jm000018k</pub-id><?supplied-pmid 10882358?><pub-id pub-id-type="pmid">10882358</pub-id></element-citation></ref><ref id="cit2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>M. J.</given-names></name></person-group><source>Chem. Rev.</source><year>1989</year><volume>89</volume><fpage>1563</fpage><lpage>1579</lpage><pub-id pub-id-type="doi">10.1021/cr00097a011</pub-id></element-citation></ref><ref id="cit3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muri</surname><given-names>E. M.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Nieto</surname><given-names>M. J.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Sindelar</surname><given-names>R. D.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Williamson</surname><given-names>J. S.</given-names></name></person-group><source>Curr. Med. Chem.</source><year>2002</year><volume>9</volume><fpage>1631</fpage><lpage>1653</lpage><pub-id pub-id-type="doi">10.2174/0929867023369402</pub-id><?supplied-pmid 12171558?><pub-id pub-id-type="pmid">12171558</pub-id></element-citation></ref><ref id="cit4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marmion</surname><given-names>C. J.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Griffith</surname><given-names>D.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Nolan</surname><given-names>K. B.</given-names></name></person-group><source>Eur. J. Inorg. Chem.</source><year>2004</year><volume>2004</volume><fpage>3003</fpage><lpage>3016</lpage><pub-id pub-id-type="doi">10.1002/ejic.200400221</pub-id></element-citation></ref><ref id="cit5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parvathy</surname><given-names>S.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Hussain</surname><given-names>I.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Karran</surname><given-names>E. H.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Turner</surname><given-names>A. J.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Hooper</surname><given-names>N. M.</given-names></name></person-group><source>Biochemistry</source><year>1998</year><volume>37</volume><fpage>1680</fpage><lpage>1685</lpage><pub-id pub-id-type="doi">10.1021/bi972034y</pub-id><?supplied-pmid 9484239?><pub-id pub-id-type="pmid">9484239</pub-id></element-citation></ref><ref id="cit6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alterio</surname><given-names>V.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Di Fiore</surname><given-names>A.</given-names></name></person-group><person-group person-group-type="author"><name><surname>D'Ambrosio</surname><given-names>K.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Supuran</surname><given-names>C. T.</given-names></name></person-group><person-group person-group-type="author"><name><surname>De Simone</surname><given-names>G.</given-names></name></person-group><source>Chem. Rev.</source><year>2012</year><volume>112</volume><fpage>4421</fpage><lpage>4468</lpage><pub-id pub-id-type="doi">10.1021/cr200176r</pub-id><?supplied-pmid 22607219?><pub-id pub-id-type="pmid">22607219</pub-id></element-citation></ref><ref id="cit7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Supuran</surname><given-names>C. T.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Scozzafava</surname><given-names>A.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Casini</surname><given-names>A.</given-names></name></person-group><source>Med. Res. Rev.</source><year>2003</year><volume>23</volume><fpage>146</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.1002/med.10025</pub-id><?supplied-pmid 12500287?><pub-id pub-id-type="pmid">12500287</pub-id></element-citation></ref><ref id="cit8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scozzafava</surname><given-names>A.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Supuran</surname><given-names>C. T.</given-names></name></person-group><source>J. Med. Chem.</source><year>2000</year><volume>43</volume><fpage>3677</fpage><lpage>3687</lpage><pub-id pub-id-type="doi">10.1021/jm000027t</pub-id><?supplied-pmid 11020282?><pub-id pub-id-type="pmid">11020282</pub-id></element-citation></ref><ref id="cit9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>T. A.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Witter</surname><given-names>D. J.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Belvedere</surname><given-names>S.</given-names></name></person-group><source>J. Med. Chem.</source><year>2003</year><volume>46</volume><fpage>5097</fpage><lpage>5116</lpage><pub-id pub-id-type="doi">10.1021/jm0303094</pub-id><?supplied-pmid 14613312?><pub-id pub-id-type="pmid">14613312</pub-id></element-citation></ref><ref id="cit10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finnin</surname><given-names>M. S.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Donigian</surname><given-names>J. R.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>A.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Richon</surname><given-names>V. M.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Rifkind</surname><given-names>R. A.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Marks</surname><given-names>P. A.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Breslow</surname><given-names>R.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Pavletich</surname><given-names>N. P.</given-names></name></person-group><source>Nature</source><year>1999</year><volume>401</volume><fpage>188</fpage><lpage>193</lpage><pub-id pub-id-type="doi">10.1038/43710</pub-id><?supplied-pmid 10490031?><pub-id pub-id-type="pmid">10490031</pub-id></element-citation></ref><ref id="cit11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mock</surname><given-names>W. L.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>H.</given-names></name></person-group><source>Biochemistry</source><year>2000</year><volume>39</volume><fpage>13945</fpage><lpage>13952</lpage><pub-id pub-id-type="doi">10.1021/bi001497s</pub-id><?supplied-pmid 11076537?><pub-id pub-id-type="pmid">11076537</pub-id></element-citation></ref><ref id="cit12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whittaker</surname><given-names>M.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Floyd</surname><given-names>C. D.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Brown</surname><given-names>P.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Gearing</surname><given-names>A. J. H.</given-names></name></person-group><source>Chem. Rev.</source><year>1999</year><volume>99</volume><fpage>2735</fpage><lpage>2776</lpage><pub-id pub-id-type="doi">10.1021/cr9804543</pub-id><?supplied-pmid 11749499?><pub-id pub-id-type="pmid">11749499</pub-id></element-citation></ref><ref id="cit13"><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Verma</surname><given-names>R. P.</given-names></name></person-group>, <source>Matrix Metalloproteinase Inhibitors: Specificity of Binding and Structure-Activity Relationships</source>, ed. <person-group person-group-type="editor"><string-name>S. P. Gupta</string-name></person-group>, <publisher-name>Springer</publisher-name>, <publisher-loc>Basel</publisher-loc>, <year>2012</year>, pp. 137&#x02013;176</mixed-citation></ref><ref id="cit14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shapiro</surname><given-names>S. D.</given-names></name></person-group><source>Curr. Opin. Cell Biol.</source><year>1998</year><volume>10</volume><fpage>602</fpage><lpage>608</lpage><pub-id pub-id-type="doi">10.1016/S0955-0674(98)80035-5</pub-id><?supplied-pmid 9818170?><pub-id pub-id-type="pmid">9818170</pub-id></element-citation></ref><ref id="cit15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johansson</surname><given-names>N.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Ahonen</surname><given-names>M.</given-names></name></person-group><person-group person-group-type="author"><name><surname>K&#x000e4;h&#x000e4;ri</surname><given-names>V.-M.</given-names></name></person-group><source>Cell. Mol. Life Sci.</source><year>2000</year><volume>57</volume><fpage>5</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1007/s000180050495</pub-id><?supplied-pmid 10949577?><pub-id pub-id-type="pmid">10949577</pub-id></element-citation></ref><ref id="cit16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kerkel&#x000e4;</surname><given-names>E.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Saarialho-Kere</surname><given-names>U.</given-names></name></person-group><source>Exp. Dermatol.</source><year>2003</year><volume>12</volume><fpage>109</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1034/j.1600-0625.2003.120201.x</pub-id><?supplied-pmid 12702139?><pub-id pub-id-type="pmid">12702139</pub-id></element-citation></ref><ref id="cit17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rudek</surname><given-names>M. A.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Venitz</surname><given-names>J.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Figg</surname><given-names>W. D.</given-names></name></person-group><source>Pharmacotherapy</source><year>2002</year><volume>22</volume><fpage>705</fpage><lpage>720</lpage><pub-id pub-id-type="doi">10.1592/phco.22.9.705.34062</pub-id><?supplied-pmid 12066962?><pub-id pub-id-type="pmid">12066962</pub-id></element-citation></ref><ref id="cit18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chauhan</surname><given-names>V. P.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Stylianopoulos</surname><given-names>T.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Boucher</surname><given-names>Y.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Jain</surname><given-names>R. K.</given-names></name></person-group><source>Annu. Rev. Chem. Biomol. Eng.</source><year>2011</year><volume>2</volume><fpage>281</fpage><lpage>298</lpage><pub-id pub-id-type="doi">10.1146/annurev-chembioeng-061010-114300</pub-id><?supplied-pmid 22432620?><pub-id pub-id-type="pmid">22432620</pub-id></element-citation></ref><ref id="cit19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boucher</surname><given-names>Y.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Baxter</surname><given-names>L. T.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Jain</surname><given-names>R. K.</given-names></name></person-group><source>Cancer Res.</source><year>1990</year><volume>50</volume><fpage>4478</fpage><lpage>4484</lpage><pub-id pub-id-type="pmid">2369726</pub-id></element-citation></ref><ref id="cit20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minchinton</surname><given-names>A. I.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Tannock</surname><given-names>I. F.</given-names></name></person-group><source>Nat. Rev. Cancer</source><year>2006</year><volume>6</volume><fpage>583</fpage><lpage>592</lpage><pub-id pub-id-type="doi">10.1038/nrc1893</pub-id><?supplied-pmid 16862189?><pub-id pub-id-type="pmid">16862189</pub-id></element-citation></ref><ref id="cit21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vandenbroucke</surname><given-names>R. E.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Libert</surname><given-names>C.</given-names></name></person-group><source>Nat. Rev. Drug Discovery</source><year>2014</year><volume>13</volume><fpage>904</fpage><lpage>927</lpage><pub-id pub-id-type="doi">10.1038/nrd4390</pub-id><?supplied-pmid 25376097?><pub-id pub-id-type="pmid">25376097</pub-id></element-citation></ref><ref id="cit22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hambley</surname><given-names>T. W.</given-names></name></person-group><source>Science</source><year>2007</year><volume>318</volume><fpage>1392</fpage><lpage>1393</lpage><pub-id pub-id-type="doi">10.1126/science.1150504</pub-id><?supplied-pmid 18048674?><pub-id pub-id-type="pmid">18048674</pub-id></element-citation></ref><ref id="cit23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munteanu</surname><given-names>C. R.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Suntharalingam</surname><given-names>K.</given-names></name></person-group><source>Dalton Trans.</source><year>2015</year><volume>44</volume><fpage>13796</fpage><lpage>13808</lpage><pub-id pub-id-type="doi">10.1039/C5DT02101D</pub-id><?supplied-pmid 26148776?><pub-id pub-id-type="pmid">26148776</pub-id></element-citation></ref><ref id="cit24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Failes</surname><given-names>T. W.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Cullinane</surname><given-names>C.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Diakos</surname><given-names>C. I.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>N.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Lyons</surname><given-names>J. G.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Hambley</surname><given-names>T. W.</given-names></name></person-group><source>Chem.&#x02013;Eur. J.</source><year>2007</year><volume>13</volume><fpage>2974</fpage><lpage>2982</lpage><pub-id pub-id-type="doi">10.1002/chem.200601137</pub-id><?supplied-pmid 17171733?><pub-id pub-id-type="pmid">17171733</pub-id></element-citation></ref><ref id="cit25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Failes</surname><given-names>T. W.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Hambley</surname><given-names>T. W.</given-names></name></person-group><source>Dalton Trans.</source><year>2006</year><volume>6</volume><fpage>1895</fpage><lpage>1901</lpage><pub-id pub-id-type="doi">10.1039/B512322D</pub-id><?supplied-pmid 16585977?><pub-id pub-id-type="pmid">16585977</pub-id></element-citation></ref><ref id="cit26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>N.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Danos</surname><given-names>S.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Bonnitcha</surname><given-names>P. D.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Failes</surname><given-names>T. W.</given-names></name></person-group><person-group person-group-type="author"><name><surname>New</surname><given-names>E. J.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Hambley</surname><given-names>T. W.</given-names></name></person-group><source>J. Biol. Inorg Chem.</source><year>2008</year><volume>13</volume><fpage>861</fpage><lpage>871</lpage><pub-id pub-id-type="doi">10.1007/s00775-008-0374-7</pub-id><?supplied-pmid 18418632?><pub-id pub-id-type="pmid">18418632</pub-id></element-citation></ref><ref id="cit27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonnitcha</surname><given-names>P. D.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Kim</surname><given-names>B. J.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Hocking</surname><given-names>R. K.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Clegg</surname><given-names>J. K.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Turner</surname><given-names>P.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Neville</surname><given-names>S. M.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Hambley</surname><given-names>T. W.</given-names></name></person-group><source>Dalton Trans.</source><year>2012</year><volume>41</volume><fpage>11293</fpage><lpage>11304</lpage><pub-id pub-id-type="doi">10.1039/C2DT30727H</pub-id><?supplied-pmid 22885674?><pub-id pub-id-type="pmid">22885674</pub-id></element-citation></ref><ref id="cit28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alimi</surname><given-names>M.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Allam</surname><given-names>A.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Selkti</surname><given-names>M.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Tomas</surname><given-names>A.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Roussel</surname><given-names>P.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Galardon</surname><given-names>E.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Artaud</surname><given-names>I.</given-names></name></person-group><source>Inorg. Chem.</source><year>2012</year><volume>51</volume><fpage>9350</fpage><lpage>9356</lpage><pub-id pub-id-type="doi">10.1021/ic301090t</pub-id><?supplied-pmid 22905650?><pub-id pub-id-type="pmid">22905650</pub-id></element-citation></ref><ref id="cit29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noh</surname><given-names>H.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Jeong</surname><given-names>D.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Ohta</surname><given-names>T.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Ogura</surname><given-names>T.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Valentine</surname><given-names>J. S.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Cho</surname><given-names>J.</given-names></name></person-group><source>J. Am. Chem. Soc.</source><year>2017</year><volume>139</volume><fpage>10960</fpage><lpage>10963</lpage><pub-id pub-id-type="doi">10.1021/jacs.7b04479</pub-id><?supplied-pmid 28758392?><pub-id pub-id-type="pmid">28758392</pub-id></element-citation></ref><ref id="cit30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacobsen</surname><given-names>F. E.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>J. A.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>S. M.</given-names></name></person-group><source>J. Am. Chem. Soc.</source><year>2006</year><volume>128</volume><fpage>3156</fpage><lpage>3157</lpage><pub-id pub-id-type="doi">10.1021/ja057957s</pub-id><?supplied-pmid 16522091?><pub-id pub-id-type="pmid">16522091</pub-id></element-citation></ref><ref id="cit31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brennan</surname><given-names>B. J.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Rudshteyn</surname><given-names>B.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Chaudhuri</surname><given-names>S.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Mercado</surname><given-names>B. Q.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Batista</surname><given-names>V. S.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Crabtree</surname><given-names>R. H.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Brudvig</surname><given-names>G. W.</given-names></name></person-group><source>Chem. Commun.</source><year>2016</year><volume>52</volume><fpage>2972</fpage><lpage>2975</lpage><pub-id pub-id-type="doi">10.1039/C5CC09857B</pub-id><?supplied-pmid 26781247?><pub-id pub-id-type="pmid">26781247</pub-id></element-citation></ref><ref id="cit32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>D. F.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Jakubovic</surname><given-names>D. A.</given-names></name></person-group><source>J. Chem. Soc., Dalton Trans.</source><year>1988</year><fpage>2927</fpage><lpage>2933</lpage><pub-id pub-id-type="doi">10.1039/DT9880002927</pub-id></element-citation></ref><ref id="cit33"><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Cotton</surname><given-names>F. A.</given-names></name></person-group> and <person-group person-group-type="author"><name><surname>Wilkinson</surname><given-names>G.</given-names></name></person-group>, <source>Advanced Inorganic Chemistry</source>, <publisher-name>Wiley</publisher-name>, <publisher-loc>New York</publisher-loc>, <year>1988</year></mixed-citation></ref><ref id="cit34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Makowska-Grzyska</surname><given-names>M. M.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Szajna</surname><given-names>E.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Shipley</surname><given-names>C.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Arif</surname><given-names>A. M.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>M. H.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Halfen</surname><given-names>J. A.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Berreau</surname><given-names>L. M.</given-names></name></person-group><source>Inorg. Chem.</source><year>2003</year><volume>42</volume><fpage>7472</fpage><lpage>7488</lpage><pub-id pub-id-type="doi">10.1021/ic034810y</pub-id><?supplied-pmid 14606843?><pub-id pub-id-type="pmid">14606843</pub-id></element-citation></ref><ref id="cit35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Codd</surname><given-names>R.</given-names></name></person-group><source>Coord. Chem. Rev.</source><year>2008</year><volume>252</volume><fpage>1387</fpage><lpage>1408</lpage><pub-id pub-id-type="doi">10.1016/j.ccr.2007.08.001</pub-id></element-citation></ref><ref id="cit36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsui</surname><given-names>T.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Kitagawa</surname><given-names>Y.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Okumura</surname><given-names>M.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Shigeta</surname><given-names>Y.</given-names></name></person-group><source>J. Phys. Chem. A</source><year>2015</year><volume>119</volume><fpage>369</fpage><lpage>376</lpage><pub-id pub-id-type="doi">10.1021/jp508308y</pub-id><?supplied-pmid 25514626?><pub-id pub-id-type="pmid">25514626</pub-id></element-citation></ref><ref id="cit37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antoni</surname><given-names>C.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Vera</surname><given-names>L.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Devel</surname><given-names>L.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Catalani</surname><given-names>M. P.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Czarny</surname><given-names>B.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Cassar-Lajeunesse</surname><given-names>E.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Nuti</surname><given-names>E.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Rossello</surname><given-names>A.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Dive</surname><given-names>V.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Stura</surname><given-names>E. A.</given-names></name></person-group><source>J. Struct. Biol.</source><year>2013</year><volume>182</volume><fpage>246</fpage><lpage>254</lpage><pub-id pub-id-type="doi">10.1016/j.jsb.2013.03.015</pub-id><?supplied-pmid 23567804?><pub-id pub-id-type="pmid">23567804</pub-id></element-citation></ref></ref-list></back></article>